– UK, Brentford – GSK plc (LON/NYSE: GSK) today announced the appointment of Wendy Becker to its Board as an Independent Non-Executive Director with effect from 1 October 2023.
“I am delighted to welcome Wendy to GSK. Wendy is a highly experienced non-executive director and has held significant leadership positions in a wide range of global businesses, including several in the technology and life sciences sectors. I’m sure she will make a significant contribution to the Board and we look forward to her joining in October.” said Board chair, Sir Jonathan Symonds.
Wendy Becker will also join the Remuneration Committee and will succeed Urs Rohner as Chair of the Remuneration Committee after the 2024 AGM.
About Wendy Becker
Wendy Becker is currently Chair of Logitech International S.A., and a Board member and Chair of the Compensation Committee of Sony Group Corporation. She has strong executive management experience including senior roles at McKinsey & Company, TalkTalk, and Vodafone, and as CEO at Jack Wills. Within the life sciences sector, Wendy is a Board member and Chair of the Remuneration Committee of Oxford Nanopore Technologies plc. She is a member of the governing bodies of the University of Oxford and related subsidiaries.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
SOURCE: https://www.gsk.com/en-gb/home/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.